John Gordon Freund, Insider at Dicerna Pharmaceuticals Inc (DRNA), sold 37,532 shares at $26.02 ($977K) on 2015-02-20, disclosed to the SEC on 2015-02-24.
Scheduled sale ($977k) by Insider under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| COLL | SELL | 2025-08-12 | $801K | — | Filing → |
| SIBN | SELL | 2025-08-11 | $388K | — | Filing → |
| COLL | SELL | 2025-06-11 | $404K | — | Filing → |